(Q32034638)

English

Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Matarredona ER

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Santiago M

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Venero JL

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Cano J

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Machado A

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

351-360

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2001.00056.X

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32034638&oldid=1588003011"